Literature DB >> 20974143

Secondary necrosis: the natural outcome of the complete apoptotic program.

Manuel T Silva1.   

Abstract

The predominant definition of apoptosis considers that the elimination of the apoptosing cell is by heterolytic degradation following phagocytosis by an assisting scavenger (efferocytosis). However, an alternative and largely underestimated outcome of apoptosis is secondary necrosis, an autolytic process of cell disintegration with release of cell components that occurs when there is no intervention of scavengers and the full apoptotic program is completed. Secondary necrosis is the typical outcome of apoptosis in unicellular eukaryotes but, importantly, it may also occur in multicellular animals and has been implicated in the genesis of important human pathologies. Secondary necrosis is a mode of cell elimination with specific molecular and morphological features and should be considered the natural outcome of the complete apoptotic program.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20974143     DOI: 10.1016/j.febslet.2010.10.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  145 in total

1.  Nanoconjugation: A Materials Approach to Enhance Epidermal Growth Factor Induced Apoptosis.

Authors:  Linxi Wu; Xinwei Yu; Amin Feizpour; Björn M Reinhard
Journal:  Biomater Sci       Date:  2014-02-01       Impact factor: 6.843

2.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.

Authors:  María José Hernández-Corbacho; Daniel Canals; Mohamad M Adada; Mengling Liu; Can E Senkal; Jae Kyo Yi; Cungui Mao; Chiara Luberto; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

3.  Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.

Authors:  A Wree; C D Johnson; J Font-Burgada; A Eguchi; D Povero; M Karin; A E Feldstein
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

Review 4.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

Review 5.  In life there is death: How epithelial tissue barriers are preserved despite the challenge of apoptosis.

Authors:  Kinga Duszyc; Guillermo A Gomez; Kate Schroder; Matthew J Sweet; Alpha S Yap
Journal:  Tissue Barriers       Date:  2017-07-07

Review 6.  Apoptosis and Vocal Fold Disease: Clinically Relevant Implications of Epithelial Cell Death.

Authors:  Carolyn K Novaleski; Bruce D Carter; M Preeti Sivasankar; Sheila H Ridner; Mary S Dietrich; Bernard Rousseau
Journal:  J Speech Lang Hear Res       Date:  2017-05-24       Impact factor: 2.297

7.  Quantification of Efferocytosis by Single-cell Fluorescence Microscopy.

Authors:  Kyle Taruc; Charles Yin; Daniel G Wootton; Bryan Heit
Journal:  J Vis Exp       Date:  2018-08-18       Impact factor: 1.355

Review 8.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

9.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

10.  Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.

Authors:  Mauricio S Caetano; Ahmed I Younes; Hampartsoum B Barsoumian; Michael Quigley; Hari Menon; Chan Gao; Thomas Spires; Timothy P Reilly; Alexandra P Cadena; Taylor R Cushman; Jonathan E Schoenhals; Ailin Li; Quynh-Nhu Nguyen; Maria Angelica Cortez; James W Welsh
Journal:  Clin Cancer Res       Date:  2019-09-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.